SENSEX
NIFTY
GOLD
USD/INR

Weather

image 20    C

Economy News

The Economic Times

Economy / The Economic Times

details

Mounjaro sales dip amid price war as semaglutide generics gain ground

Mounjaro, the star pharmaceutical from Eli Lilly, is experiencing a downturn in sales across India. This slump can be attributed to competitor Novo Nordisk slashing prices on their famed Ozempic and Wegovy, not to mention the influx of cost-effective semaglutide generics. Despite this, Lilly remains optimistic about the distinct advantages Mounjaro brings to its users.

10 Apr 2026 12:38 am